USP -- Highlighting Its Legal Role In Naming -- Backs WHO Plan For Distinguishable Biologic Names

The United States Pharmacopeial Convention this week came out in support of the World Health Organization's plan to give biologics a four-letter code added to International Nonproprietary Names, praising WHO for applying the plan to all biologics and not changing the underlying INN. USP highlighted that product labels must include official titles recognized by USP and FDA only can supersede names designated by USP through the rulemaking process. The key stakeholder weighed in with comments on Sept. 19 as feedback...